DSM and Crucell Announce Record Achievement in PER.C6 Technology (17 Jun 2008)
DSM Biologics and Crucell N.V. announced a breakthrough in the production of IgGantibodies using PER.C6® technology. By employing the PER.C6® human cell line and proprietary XD(TM) technology, a record yield of over 27 grams per liter...
Affimed validates antibody target for cancer metastasis (14 May 2008) IgGantibodies, siRNAs and small molecules (polysulfated glycanes).The effects... of antibodies or other therapeutic interventions. The target, 37 kDa/67 kDa.... The single chain and full length antibodies were able to reduce invasion by 30% and 40...
Abgenix Introduces Enhanced Version of XenoMouse Technology (05 Dec 2001) of XenoMouse® mice that produce fully human monoclonal antibodies that contain both... in the commercial sector make human antibodies that contain only kappa light chains. Abgenix expects these strains of mice, making both human IgG kappa and human IgG lambda...
Top